Absci anticipates ABS-201 interim proof of concept data in 2H 2026, while guiding cash runway into 2H 2028

Data ReadoutABS-201Neutral

AI Analysis

Absci anticipates interim proof of concept data for ABS-201 in the second half of 2026 and has guided cash runway to the second half of 2028.

Guidance

Cash runway into 2H 2028

Interim proof of concept data expected

Importance:5/10

Sentiment:

0.00

clinical_trialcash_guidancedata_readout

Related Companies

Read the original article

Published by Seeking Alpha Healthcare on August 11, 2026 11:48 PM